Mammotome® Markers
A Global Leader in Breast Biopsy Markers
The most comprehensive marker portfolio, offering a solution for any patient or provider need
Long-Term Ultrasound Visibility
Markers with exclusive hydrogel carriers provide unmatched long-term ultrasound visibility.1 Preoperative localization performed under ultrasound can create a faster, more comfortable patient experience.2
Placement Stability
Unique features that anchor the marker within the biopsy cavity.
Multiple, Unique 3D Shapes
Identify multiple biopsy sites through highly distinct, three-dimensional shapes, clearly visible under all imaging modalities.3-5
Hemostatic Support
Support patients’ post-biopsy healing using bovine collagen. Collagen has been shown in certain studies to help prevent excessive bleeding.6-8
All-Natural Options
Non-metal marking alternatives are available for patients with unique sensitivities or personal preferences.
Empower Your Practice With Our Full Suite:
HydroMARK™ Breast Biopsy Site Marker
Enduring exclusive hydrogel technology provides long-term ultrasound visibility in percutaneous breast biopsy procedures, including axillary lymph nodes.9
HydroMARK™ Plus Breast Biopsy Site Marker
Same great benefits of the original HydroMARK™ markers, with added features designed to alleviate displacement during surgical excision, enhance visibility and ease of locating.10-12
MammoMARK® Biopsy Site Identifier
Rapid collagen expansion anchors the marker within the biopsy cavity reducing the likelihood of movement.8,13,14
MammoSTAR® Biopsy Site Marker & BiomarC® Biopsy Site Marker
All-natural biopsy markers providing non-metal marking alternatives, with or without a long-lasting beta glucan carrier for unique patient sensitivities.
LumiMARK™ Biopsy Site Marker
Three multifaceted nitinol shapes designed for easy identification from any angle.3-5
Interested in Learning More?
Contact us to learn how Mammotome® Markers can help benefit your practice.
Additional Resources
Frequently Asked Questions
Every patient presents a unique combination of anatomy, lesion characteristics, and clinical context. Factors such as biopsy modality, lesion size or location, breast density, and future imaging plans can influence which marker is most appropriate.
Mammotome offers a comprehensive portfolio of breast biopsy site markers designed to meet specific clinical needs. Our portfolio gives you the flexibility to choose the right solution for each patient, empowering you to deliver more personalized care.
Related Products
Mammotome Revolve™ System
Redefining procedural efficiency without compromising tissue quality – from positioning to diagnosis.
Mammotome® Elite Device
Combines vacuum-assisted biopsy tissue quality with the ease and speed of a spring-loaded core needle.
Mammotome DualCore™
Lightweight, precise, and reliable, offering a spring-loaded action for quality sampling capability.
Would you like more information about a specific Mammotome® Marker?
1. Sakamoto, N., Fukuma, E., Tsunoda, Y. et al. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel based breast biopsy site marker. Breast Cancer 25, 575–582 (2018). https://doi.org/10.1007/s12282-018-0854-8
2. Gentile, Ann Surg Oncol. 2016 Oct;23(10):3284-9. doi: 10.1245/s10434-016-5325-x. Epub 2016 Jun 23.
3. LumiMARK™ Device Test: PCR-000340 System Design
4. LumiMARK™ Device Test: PCR-000579 Summative Usability
5. LumiMARK™ Device Test: ES-002647 Claims Assessment
6. Pinkney DM, Mychajlowycz M, Shah BA. A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers. Br J Radiol 2016; 89: 20160149. Page 4, middle right
7. Taghreed I Alshafeiy, Alison Matich, Carrie M Rochman, Jennifer A Harvey, Advantages and Challenges of Using Breast Biopsy Markers, Journal of Breast Imaging, Volume 4, Issue 1, January/February 2022, Pages 78–95, https://doi.org/10.1093/jbi/wbab052
8. Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181(5):1295-9. doi: 10.2214/ajr.181.5.1811295. PMID: 14573422.
9. Indication for lymph node using HydroMARK™ markers is limited to the United States and Canada with other country registrations pending.
10. HydroMARK™ Device Test – PCR-000414, Summative Usability
11. HydroMARK™ Design Plan – ADD-00013 Rev G, Page 15
12. HydroMARK™ Device Test – PCR-000299, SDR0098 Vacuum Suction Testing
13. MammoMARK® Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
14. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins.The American Journal of Surgery, 209(6), 950-958
HydroMARK™ marker ultrasound photo courtesy of Dr. Robin Shermis, ProMedica Breast Care of Toledo
MammoMARK® marker mammography photo courtesy of Dr. Kimberly C. Hutcherson, North Metropolitan Radiology Associates, LLC
Products may not be approved or available in your region. Please check with your local Mammotome representative.